Detailed answers about CHILDLESSNESS OVERCOME THROUGH SURROGACY LIMITED, including incorporation, status, business activity, and accounts information.
When was CHILDLESSNESS OVERCOME THROUGH SURROGACY LIMITED founded?
CHILDLESSNESS OVERCOME THROUGH SURROGACY LIMITED was officially incorporated on 25 April 2019 and is registered under company number 11962596. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CHILDLESSNESS OVERCOME THROUGH SURROGACY LIMITED?
PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of CHILDLESSNESS OVERCOME THROUGH SURROGACY LIMITED?
CHILDLESSNESS OVERCOME THROUGH SURROGACY LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CHILDLESSNESS OVERCOME THROUGH SURROGACY LIMITED do?
CHILDLESSNESS OVERCOME THROUGH SURROGACY LIMITED operates in the following sector: 96090 - Other service activities n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is CHILDLESSNESS OVERCOME THROUGH SURROGACY LIMITED's registered address?
The registered office address of CHILDLESSNESS OVERCOME THROUGH SURROGACY LIMITED is FOXY HOUSE 41 FOX HILL ROAD, GUILDEN MORDEN, ROYSTON, ENGLAND, SG8 0JH. This is the official address filed with Companies House for legal and statutory correspondence.
Is CHILDLESSNESS OVERCOME THROUGH SURROGACY LIMITED financially stable?
The most recent accounts for CHILDLESSNESS OVERCOME THROUGH SURROGACY LIMITED were made up to 30 April 2025, filed as MICRO ENTITY. Next accounts are due by 31 January 2027.